Allergy and Immunology, Allergy · Tulsa, OK
NPI
1154302354
Since 2005
Specialty
Allergy and Immunology, Allergy
Code 207KA0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
9311 S Mingo Rd
Tulsa, OK, 74133
Phone (918) 307-1613
Groups this clinician bills Medicare through
Medicare paid, 2024
$568K
25,406 services
Medicare patients, 2024
715
Average age 72
Drug cost, 2024
$4.0M
1,615 prescriptions
Company payments, 2025
$7,754
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Timothy J Nickel was code J2357 (injection, omalizumab, 5 mg), 6,810 times for 26 patients. In total Timothy J Nickel billed 25,406 services in 52 codes, and Medicare paid $568K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2357 Injection, omalizumab, 5 mg | Office | 6,810 | 26 | $29.70 | $202K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 3,900 | 17 | $34.93 | $136K |
| 95004 Test - Miscellaneous | Office | 3,144 | 64 | $2.51 | $7,877 |
| 95117 Treatment - Miscellaneous | Office | 1,212 | 345 | $7.55 | $9,148 |
| 95024 Test - Miscellaneous | Office | 1,070 | 43 | $5.54 | $5,930 |
| 95165 Treatment - Miscellaneous | Office | 622 | 59 | $9.10 | $5,658 |
| 95115 Treatment - Miscellaneous | Office | 281 | 87 | $6.51 | $1,828 |
| 96372 Injection Administration | Office | 276 | 41 | $10.43 | $2,878 |
| 99214 Office E&M - Established | Office | 188 | 151 | $84.50 | $16K |
| 99213 Office E&M - Established | Office | 155 | 136 | $62.95 | $9,757 |
| 96366 Intravenous Infusion, Hydration | Office | 130 | 11 | $14.60 | $1,898 |
| 99204 Office E&M - New | Office | 63 | 63 | $107.16 | $6,751 |
| 96365 Intravenous Infusion, Hydration | Office | 45 | 12 | $44.03 | $1,981 |
| J7060 5% dextrose/water (500 ml = 1 unit) | Office | 43 | 11 | $1.42 | $60.91 |
| 99203 Office E&M - New | Office | 31 | 31 | $67.03 | $2,078 |
By year: 2022 $556K for 26,769 services; 2023 $646K for 29,525 services; 2024 $568K for 25,406 services.
Medicare prescription drug claims, 2024
In 2024, the drug Timothy J Nickel prescribed most often to Medicare patients was Montelukast Sodium, with 256 prescriptions and refills. In total Timothy J Nickel wrote 1,615 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 256 | 592 | 81 | $4,542 |
| Epinephrine Generic | 114 | 120 | 101 | $21K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 98 | 134 | 20 | $84K |
| Azelastine Hcl Generic | 92 | 183 | 45 | $2,373 |
| Breo Ellipta Fluticasone/Vilanterol | 87 | 91 | 17 | $36K |
| Ipratropium Bromide Generic | 75 | 116 | 24 | $1,768 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 73 | 76 | 46 | $1,706 |
| Prednisone Generic | 73 | 73 | 54 | $97.39 |
| Fluticasone Propionate Generic | 70 | 146 | 35 | $2,009 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 36 | 53 | 11 | $3,705 |
| Symbicort Budesonide/Formoterol Fumarate | 35 | 43 | 15 | $9,408 |
| Takhzyro Lanadelumab-Flyo | 33 | 33 | Under 11 | $1.7M |
| Dupixent Pen Dupilumab | 31 | 31 | Under 11 | $121K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 28 | 30 | Under 11 | $5,249 |
| Azelastine-Fluticasone Azelastine/Fluticasone | 27 | 29 | Under 11 | $2,912 |
Brand drugs: 672 claims; generic drugs: 943 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Timothy J Nickel $7,754 ($7,754 in general payments such as food, travel and fees) from 18 companies. The largest payer was Genentech USA, Inc. with $5,604.
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. ROG.SW | 23 | $5,604 |
| AstraZeneca Pharmaceuticals LP AZN | 16 | $428 |
| Genzyme Corporation SNY | 13 | $312 |
| Pharming Healthcare, Inc. | 9 | $221 |
| GlaxoSmithKline, LLC. GSK | 17 | $221 |
| Pfizer Inc. PFE | 12 | $176 |
| CSL Behring CSL.AX | 7 | $157 |
| Blueprint Medicines Corporation SNY | 5 | $136 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 5 | $106 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $104 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.